Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MAXXON, INC (MXON.Nasdaq BB) Disposable syringe technology -- Ignore unavailable to you. Want to Upgrade?

To: campe who wrote (79)	5/21/1999 2:36:00 AM
From: Stephen D. Wilson	Read Replies (1) \| Respond to of 105

IMO any one that is looking to buy or is holding this stock should flee if you think that they have a unique product. I am a paramedic in California and the law changes on July 1st to require us to go to a needle which will reduce the chance of needle sticks. Our Medical Services committee just selected a system that is being marketed by Baxter ( not sure if they actually manufacture it). It has a retractable needle system and is available for 3cc and larger syringes. The 1 cc syringe seems to be the big problem with manufacturers since it is such a narrow needle to begin with. Anyway there are several very good models and styles of retractable needle systems already out there and unless Maxxon has something really special or has a process that will reduce manufacturing costs significantly then I would say that IMO some larger more efficient companies already have the edge on the market. I do not nor have I ever owned this stock. Would just hate to see anyone lose money thinking that they were investing in a company that had a unique product. Steve